{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:09:22Z","timestamp":1774548562972,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"DOI":"10.7759\/cureus.105916","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:18:22Z","timestamp":1774545502000},"source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotic Medication Adherence Among Outpatients Attending the Centre Neuro Psycho Pathologique in Kinshasa: A Cross-Sectional Pilot Study of Treatment Attitudes, Insight, and Side-Effect Burden"],"prefix":"10.7759","author":[{"given":"Yves","family":"Tshangala Kavunga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julienne","family":"Nzuzi Mananga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jael","family":"Won Vuvu Ngimbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Ntalaja Kabuayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022, 9:137-150. 10.1016\/S2215-0366(21)00395-3","journal-title":"Lancet Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240738","article-title":"Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application","volume":"181","author":"Leucht S","year":"2024","unstructured":"Leucht S, Priller J, Davis JM. Antipsychotic drugs: a concise review of history, classification, indications, mechanism, efficacy, side effects, dosing, and clinical application. Am J Psychiatry. 2024, 181:865-878. 10.1176\/appi.ajp.20240738","journal-title":"Am J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20972","article-title":"Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants","volume":"21","author":"Ostuzzi G","year":"2022","unstructured":"Ostuzzi G, Bertolini F, Tedeschi F, et al.. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants. World Psychiatry. 2022, 21:295-307. 10.1002\/wps.20972","journal-title":"World Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro JP","year":"2002","unstructured":"Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002, 63:892-909. 10.4088\/jcp.v63n1007","journal-title":"J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S42735","article-title":"Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies","volume":"5","author":"Haddad PM","year":"2014","unstructured":"Haddad PM, Brain C, Scott J. Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas. 2014, 5:43-62. 10.2147\/PROM.S42735","journal-title":"Patient Relat Outcome Meas"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi K","year":"2013","unstructured":"Higashi K, Medic G, Littlewood KJ, Diez T, Granstr\u00f6m O, De Hert M. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013, 3:200-218. 10.1177\/2045125312474019","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S41609","article-title":"Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia","volume":"7","author":"Dilla T","year":"2013","unstructured":"Dilla T, Ciudad A, Alvarez M. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence. 2013, 7:275-284. 10.2147\/PPA.S41609","journal-title":"Patient Prefer Adherence"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","volume":"225","author":"Sendt KV","year":"2015","unstructured":"Sendt KV, Tracy DK, Bhattacharyya S. A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders. Psychiatry Res. 2015, 225:14-30. 10.1016\/j.psychres.2014.11.002","journal-title":"Psychiatry Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-21647-6","article-title":"Non-adherence with the treatment regimen and its associated factors among patients with schizophrenia in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"15","author":"Addisu ZD","year":"2025","unstructured":"Addisu ZD, Demsie DG, Tafere C, et al.. Non-adherence with the treatment regimen and its associated factors among patients with schizophrenia in Sub-Saharan Africa: a systematic review and meta-analysis. Sci Rep. 2025, 15:37843. 10.1038\/s41598-025-21647-6","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280089","article-title":"Mental health care in the city of Lubumbashi, Democratic Republic of the Congo: analysis of demand, supply and operational response capacity of the health district of Tshamilemba","volume":"18","author":"Mayoyo EM","year":"2023","unstructured":"Mayoyo EM, Criel B, Michielsen J, Chuy D, Coppieters Y, Chenge F. Mental health care in the city of Lubumbashi, Democratic Republic of the Congo: analysis of demand, supply and operational response capacity of the health district of Tshamilemba. PLoS One. 2023, 18:e0280089. 10.1371\/journal.pone.0280089","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan TP","year":"1983","unstructured":"Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med. 1983, 13:177-183. 10.1017\/s0033291700050182","journal-title":"Psychol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","article-title":"A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change","volume":"89","author":"Birchwood M","year":"1994","unstructured":"Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994, 89:62-67. 10.1111\/j.1600-0447.1994.tb01487.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107087976","article-title":"A new self-rating scale for detecting atypical or second-generation antipsychotic side effects","volume":"22","author":"Waddell L","year":"2008","unstructured":"Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol. 2008, 22:238-243. 10.1177\/0269881107087976","journal-title":"J Psychopharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.. Lancet. 2007, 370:1453-1457. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref15","unstructured":"World Population Prospects. (2024). Accessed. February 24, 2026: https:\/\/population.un.org\/wpp\/publications."},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1192\/S1749367600005737","article-title":"Mental health in the Democratic Republic of Congo: a post-crisis country challenge","volume":"7","author":"On'okoko MO","year":"2010","unstructured":"On'okoko MO, Jenkins R, Miezi SM, Andjafono DO, Mushidi IM. Mental health in the Democratic Republic of Congo: a post-crisis country challenge. Int Psychiatry. 2010, 7:41-42.","journal-title":"Int Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10219-x","article-title":"Understanding the mix of services for mental health care in urban DR Congo: a qualitative descriptive study","volume":"23","author":"Mayoyo EM","year":"2023","unstructured":"Mayoyo EM, Criel B, Sow A, Coppieters Y, Chenge F. Understanding the mix of services for mental health care in urban DR Congo: a qualitative descriptive study. BMC Health Serv Res. 2023, 23:1206. 10.1186\/s12913-023-10219-x","journal-title":"BMC Health Serv Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1192\/pb.21.4.224","article-title":"Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications","volume":"21","author":"Atkins M","year":"1997","unstructured":"Atkins M, Burgess A, Bottomley C, Riccio M. Chlorpromazine equivalents: a consensus of opinion for both clinical and research applications. Psychiatr Bull. 1997, 21:224-226. 10.1192\/pb.21.4.224","journal-title":"Psychiatr Bull"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner DM","year":"2010","unstructured":"Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010, 167:686-693. 10.1176\/appi.ajp.2009.09060802","journal-title":"Am J Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada T","year":"2015","unstructured":"Inada T, Inagaki A. Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 2015, 69:440-447. 10.1111\/pcn.12275","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbv037","article-title":"Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method","volume":"41","author":"Leucht S","year":"2015","unstructured":"Leucht S, Samara M, Heres S, et al.. Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull. 2015, 41:1397-1402. 10.1093\/schbul\/sbv037","journal-title":"Schizophr Bull"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0920-9964(99)00130-9","article-title":"Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses","volume":"42","author":"Thompson K","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000, 42:241-247. 10.1016\/s0920-9964(99)00130-9","journal-title":"Schizophr Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.10.029","article-title":"A large-scale validation study of the Medication Adherence Rating Scale (MARS)","volume":"100","author":"Fialko L","year":"2008","unstructured":"Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, Freeman D. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008, 100:53-59. 10.1016\/j.schres.2007.10.029","journal-title":"Schizophr Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-020-01207-x","article-title":"Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers","volume":"271","author":"Verdoux H","year":"2021","unstructured":"Verdoux H, Quiles C, Bon L, et al.. Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers. Eur Arch Psychiatry Clin Neurosci. 2021, 271:1415-1424. 10.1007\/s00406-020-01207-x","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/srep31598","article-title":"Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: results from the French housing first experience","volume":"6","author":"Zemmour K","year":"2016","unstructured":"Zemmour K, Tinland A, Boucekine M, et al.. Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: results from the French housing first experience. Sci Rep. 2016, 6:31598. 10.1038\/srep31598","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2014.12.007","article-title":"Effects on cognitive and clinical insight with the use of guided self-determination in outpatients with schizophrenia: a randomized open trial","volume":"30","author":"J\u00f8rgensen R","year":"2015","unstructured":"J\u00f8rgensen R, Licht RW, Lysaker PH, et al.. Effects on cognitive and clinical insight with the use of guided self-determination in outpatients with schizophrenia: a randomized open trial. Eur Psychiatry. 2015, 30:655-663. 10.1016\/j.eurpsy.2014.12.007","journal-title":"Eur Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.024653","article-title":"Insight in psychosis: influence of cognitive ability and self-esteem","volume":"191","author":"Cooke MA","year":"2007","unstructured":"Cooke MA, Peters ER, Greenwood KE, Fisher PL, Kumari V, Kuipers E. Insight in psychosis: influence of cognitive ability and self-esteem. Br J Psychiatry. 2007, 191:234-237. 10.1192\/bjp.bp.106.024653","journal-title":"Br J Psychiatry"},{"key":"ref28","unstructured":"Glasgow Antipsychotic Side-effect Scale (GASS). https.\/\/www.rightdecisions.scot.nhs.uk\/media\/2352\/glasgow-antipsychotic-side-effect-scale-gass.pdf."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro SS","year":"1965","unstructured":"Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965, 52:591-611. 10.1093\/biomet\/52.3-4.591","journal-title":"Biometrika"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/03610928008827941","article-title":"Goodness of fit tests for the multiple logistic regression model","volume":"9","author":"Hosmer DW Jr.","year":"1980","unstructured":"Hosmer DW Jr., Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Comm Statist. 1980, 9:1043-1069. 10.1080\/03610928008827941","journal-title":"Comm Statist"},{"key":"ref31","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan DI","year":"2009","unstructured":"Velligan DI, Weiden PJ, Sajatovic M, et al.. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009, 70:1-46.","journal-title":"J Clin Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.23.2.207","article-title":"Social support and patient adherence to medical treatment: a meta-analysis","volume":"23","author":"DiMatteo MR","year":"2004","unstructured":"DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004, 23:207-218. 10.1037\/0278-6133.23.2.207","journal-title":"Health Psychol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/468370-antipsychotic-medication-adherence-among-outpatients-attending-the-centre-neuro-psycho-pathologique-in-kinshasa-a-cross-sectional-pilot-study-of-treatment-attitudes-insight-and-side-effect-burden","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:18:24Z","timestamp":1774545504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/468370-antipsychotic-medication-adherence-among-outpatients-attending-the-centre-neuro-psycho-pathologique-in-kinshasa-a-cross-sectional-pilot-study-of-treatment-attitudes-insight-and-side-effect-burden"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.105916","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}